Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tomas Kauer - Moderator

Sep 9, 2024 - 14:00

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tags:

Previous Article

BW LPG Limited “ Ex dividend USD 0.58 on the Oslo Stock Exchange today

Dollar steadies, yen slips as traders grapple with Fed rate-cut outlook

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

Oil steady as supply disruptions from Storm Francine offset weak demand

Oil steady as supply disruptions from Storm Francine of...

Tomas Kauer - Mode... Sep 10, 2024

UK seeks collaboration for security research lab to counter Russia and ‘new AI arms race’

UK seeks collaboration for security research lab to cou...

Tomas Kauer - Mode... Nov 25, 2024

Russia's RT will continue to work in the West, editor says

Russia's RT will continue to work in the West, editor says

Tomas Kauer - Mode... Sep 8, 2024